Subtopic Deep Dive
Remote Ischemic Conditioning
Research Guide
What is Remote Ischemic Conditioning?
Remote ischemic conditioning induces cardioprotective effects against myocardial ischemia-reperfusion injury through transient ischemia applied to distant organs or limbs via humoral and neural mediators.
Remote ischemic conditioning encompasses preconditioning, perconditioning, and postconditioning protocols using brief limb ischemia cycles. Preclinical studies demonstrate reduced infarct size, while clinical trials show mixed outcomes in cardiac surgery patients (Hausenloy et al., 2015; Meybohm et al., 2015). Over 700 citations document its mechanisms since Kharbanda et al. (2002) first showed limb ischemia protects remote myocardium.
Why It Matters
Remote ischemic conditioning provides a non-invasive method to limit reperfusion injury in acute coronary syndrome patients, potentially reducing myocardial infarct size beyond standard reperfusion therapy (Hausenloy and Yellon, 2013). Clinical trials like RIPHeart and CRISP tested its efficacy in CABG surgery, revealing challenges in translation from animal models (Meybohm et al., 2015; Hausenloy et al., 2015). Heusch (2015) highlights its role in multitarget strategies combining with pharmacotherapies to improve STEMI outcomes (Heusch and Gersh, 2016).
Key Research Challenges
Clinical Translation Failure
Preclinical efficacy in reducing infarct size fails in human trials due to comorbidities and anesthesia effects (Hausenloy et al., 2015). Meybohm et al. (2015) RIPHeart trial showed no benefit in 1403 cardiac surgery patients under propofol. Variability in protocols hinders standardization.
Mechanistic Uncertainty
Humoral factors like adiponectin and neural pathways remain incompletely defined despite Przyklenk et al. (1993) demonstration of remote protection. Kharbanda et al. (2002) confirmed limb ischemia induces remote effects in vivo, but signaling mediators require further elucidation (Heusch, 2015).
Trial Design Heterogeneity
Inconsistent ischemic cycle durations and patient populations across studies complicate meta-analyses (Davidson et al., 2019). Hausenloy et al. (2015) NEJM trial used 3x5-min arm ischemia without outcome improvement. Propofol anesthesia may abrogate benefits (Meybohm et al., 2015).
Essential Papers
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
Derek J. Hausenloy, Derek M. Yellon · 2013 · Journal of Clinical Investigation · 2.2K citations
Acute myocardial infarction (MI) is a major cause of death and disability worldwide. In patients with MI, the treatment of choice for reducing acute myocardial ischemic injury and limiting MI size ...
Pathophysiology of ischaemia-reperfusion injury
Donna L. Carden, D. Neil Granger · 2000 · The Journal of Pathology · 1.7K citations
Reperfusion of ischaemic tissues is often associated with microvascular dysfunction that is manifested as impaired endothelium-dependent dilation in arterioles, enhanced fluid filtration and leukoc...
Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.
Karin Przyklenk, Barbara Bauer, Michel Ovize et al. · 1993 · Circulation · 1.4K citations
BACKGROUND One or more brief episodes of coronary artery occlusion protect or "precondition" the myocardium perfused by that artery from a subsequent episode of sustained ischemia. We sought to det...
Molecular Basis of Cardioprotection
Gerd Heusch · 2015 · Circulation Research · 777 citations
Reperfusion is mandatory to salvage ischemic myocardium from infarction, but reperfusion per se contributes to injury and ultimate infarct size. Therefore, cardioprotection beyond that by timely re...
Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery
Derek J. Hausenloy, Luciano Candilio, Richard D. Evans et al. · 2015 · New England Journal of Medicine · 711 citations
Remote ischemic preconditioning did not improve clinical outcomes in patients undergoing elective on-pump CABG with or without valve surgery. (Funded by the Efficacy and Mechanism Evaluation Progra...
Transient Limb Ischemia Induces Remote Ischemic Preconditioning In Vivo
Rajesh Kharbanda, Ulrik Markus Mortensen, Paul A. White et al. · 2002 · Circulation · 707 citations
Background— Ischemic preconditioning reduces local tissue injury caused by subsequent ischemia-reperfusion (IR), but may also have a salutary effect on IR injury of tissues remote from those underg...
The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge
Gerd Heusch, Bernard J. Gersh · 2016 · European Heart Journal · 662 citations
The incidence of ST segment elevation myocardial infarction (STEMI) has decreased over the last two decades in developed countries, but mortality from STEMI despite widespread access to reperfusion...
Reading Guide
Foundational Papers
Start with Przyklenk et al. (1993) for remote protection discovery, then Kharbanda et al. (2002) for limb ischemia proof, followed by Hausenloy and Yellon (2013) for therapeutic context—these establish core concepts with 2235+ combined citations.
Recent Advances
Study Hausenloy et al. (2015) NEJM trial (711 citations) and Meybohm et al. (2015) RIPHeart (622 citations) for clinical outcomes, plus Davidson et al. (2019) on translation barriers.
Core Methods
Limb cuff protocols (3x5-min ischemia), humoral assays for mediators, and infarct size measurement via TTC staining; clinical endpoints include troponin levels and composite MACE (Hausenloy et al., 2015).
How PapersFlow Helps You Research Remote Ischemic Conditioning
Discover & Search
Research Agent uses citationGraph on Przyklenk et al. (1993) to map 1354-cited foundational remote protection studies, then findSimilarPapers reveals Kharbanda et al. (2002) limb ischemia work, and exaSearch queries 'remote ischemic conditioning clinical trials propofol' for Meybohm et al. (2015) RIPHeart analysis.
Analyze & Verify
Analysis Agent applies readPaperContent to Hausenloy et al. (2015) NEJM trial, then verifyResponse with CoVe cross-checks claims against Carden and Granger (2000) pathophysiology, and runPythonAnalysis extracts meta-analysis stats from Davidson et al. (2019) using pandas for GRADE evidence grading on translation failures.
Synthesize & Write
Synthesis Agent detects gaps in humoral mediator consensus between Heusch (2015) and Kharbanda et al. (2002), flags contradictions in trial outcomes, while Writing Agent uses latexEditText for protocol diagrams, latexSyncCitations for 10-paper bibliography, and latexCompile for review manuscript exportMermaid visualizes signaling pathways.
Use Cases
"Extract and plot infarct size reductions from remote ischemic conditioning animal studies."
Research Agent → searchPapers 'remote ischemic preconditioning infarct size' → Analysis Agent → readPaperContent (Kharbanda 2002, Przyklenk 1993) → runPythonAnalysis (pandas data extraction, matplotlib boxplots of % reductions) → researcher gets CSV of pooled effect sizes.
"Draft LaTeX review on remote ischemic conditioning trial failures with citations."
Synthesis Agent → gap detection (Hausenloy 2015 vs Meybohm 2015) → Writing Agent → latexEditText (intro + methods) → latexSyncCitations (10 papers) → latexCompile → researcher gets PDF manuscript with figures.
"Find GitHub code for remote ischemic conditioning simulations."
Research Agent → searchPapers 'remote ischemic conditioning model' → paperExtractUrls → paperFindGithubRepo → githubRepoInspect (ischemia simulation scripts) → researcher gets runnable Python models for reperfusion injury.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ remote conditioning papers via searchPapers → citationGraph → GRADE grading, producing structured report on trial heterogeneity. DeepScan applies 7-step analysis with CoVe checkpoints to verify Heusch (2015) multitarget claims against Hausenloy (2013). Theorizer generates hypotheses on neural mediators from Przyklenk (1993) + Kharbanda (2002) abstracts.
Frequently Asked Questions
What defines remote ischemic conditioning?
Remote ischemic conditioning applies brief ischemia-reperfusion cycles to limbs or organs distant from the heart, inducing protection via humoral factors and neural signals (Przyklenk et al., 1993; Kharbanda et al., 2002).
What are key methods in remote ischemic conditioning?
Protocols include 3-4 cycles of 5-min limb cuff inflation to 200 mmHg followed by 5-min reperfusion, applied as preconditioning before ischemia, perconditioning during, or postconditioning after (Hausenloy et al., 2015; Meybohm et al., 2015).
What are seminal papers on this topic?
Przyklenk et al. (1993, Circulation, 1354 citations) first showed regional preconditioning protects remote myocardium; Kharbanda et al. (2002, Circulation, 707 citations) demonstrated limb ischemia induces remote protection in vivo.
What open problems exist?
Clinical efficacy remains inconsistent due to anesthesia interference and patient variability; multitarget combinations need validation (Davidson et al., 2019; Heusch, 2015).
Research Cardiac Ischemia and Reperfusion with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Remote Ischemic Conditioning with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cardiac Ischemia and Reperfusion Research Guide